Cargando…

2157. Phase 1 Study in Healthy Chinese Subjects of Novel Prodrug, MRX-4

BACKGROUND: MRX-4 is a prodrug of contezolid (MRX-1), a new oxazilidone approved in China. We evaluated the safety and pharmacokinetic (PK) profile of IV and oral MRX-4 and its metabolites. METHODS: This randomized, double-blind, placebo-controlled study was conducted at Huashan Hospital, (Shanghai,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Haijing, Li, Size, Wang, Hailin, Cao, Guoying, Zhang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677217/ http://dx.doi.org/10.1093/ofid/ofad500.1780

Ejemplares similares

A phase I study of the safety, tolerability, and pharmacokinetics of contezolid acefosamil after intravenous and oral administration in healthy Chinese subjects
por: Yang, Haijing, et al.
Publicado: (2023)

2157. Evaluation of the Utility of the MRSA Nasal PCR Assay in a Community Healthcare System
por: Hobbs, Athena L V, et al.
Publicado: (2019)

2157. Design, Implementation, and Analysis Considerations for Cluster Randomized Trials in Infection Control and Hospital Epidemiology: A Systematic Review
por: O’Hara, Lyndsay, et al.
Publicado: (2018)

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects
por: Hu, Yingying, et al.
Publicado: (2023)

PB2157: AUTOSCT IN PATIENTS WITH MULTIPLE MYELOMA AND DIALYSIS-DEPENDENT NEPHROPATHY
por: Karimova, Ekaterina, et al.
Publicado: (2023)

SigH stress response mediates killing of Mycobacterium tuberculosis by activating nitronaphthofuran prodrugs via induction of Mrx2 expression
por: Cioetto-Mazzabò, Laura, et al.
Publicado: (2022)

Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects
por: Yang, Haijing, et al.
Publicado: (2022)

Analysis of early failure rate and its risk factor with 2157 total ankle replacements
por: Lee, Jung Woo, et al.
Publicado: (2021)

Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study
por: Li, Shanshan, et al.
Publicado: (2023)

Mechanism of MRX inhibition by Rif2 at telomeres
por: Roisné-Hamelin, Florian, et al.
Publicado: (2021)

Pharmacokinetics of Temsavir, the Active Moiety of the Prodrug Fostemsavir, in Subjects with Hepatic Impairment
por: Sevinsky, Heather, et al.
Publicado: (2017)

Antibacterial activity of the novel oxazolidinone contezolid (MRX-I) against Mycobacterium abscessus
por: Gao, Shan., et al.
Publicado: (2023)

PB2157: TREATMENT WITH DIPHENYLENEIODONIUM CHLORIDE EXHIBITS CELL GROWTH INHIBITORY EFFECTS ON AGGRESSIVE LYMPHOMA CELLS
por: Haingartner, S., et al.
Publicado: (2022)

697. Evaluation of Contezolid Activity to Anaerobic and Gram-positive-cocci Isolates from a Phase 3 Acute Bacterial Skin and Skin Structure Infection Clinical Trial (MRX-I-06)
por: Yang, Yang, et al.
Publicado: (2019)

686. Evaluation of Contezolid Activity to Anaerobic and Gram-positive-cocci Isolates from a Phase 3 Acute Bacterial Skin and Skin Structure Infection Clinical Trial (MRX-I-06)
por: Yang, Yang, et al.
Publicado: (2019)

2148. In vitro Potency of a Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Against Mycobacterium tuberculosis, Mycobacterium avium, and Mycobacterium abscessus
por: Shoen, Carolyn M, et al.
Publicado: (2023)

LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA(®) in Chinese healthy male subjects
por: Cao, Guoying, et al.
Publicado: (2023)

2157 The socially animated machine (SAM) robot: A social skills intervention for children with autism spectrum disorder
por: Lebersfeld, Jenna, et al.
Publicado: (2018)

Keeping it real: MRX–Sae2 clipping of natural substrates
por: Gnügge, Robert, et al.
Publicado: (2017)

Functions and regulation of the MRX complex at DNA double-strand breaks
por: Gobbini, Elisa, et al.
Publicado: (2016)

A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity In Vitro
por: Guo, Qi, et al.
Publicado: (2021)

2553. Safety, tolerability and pharmacokinetics of HS-10366 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase 1 trial
por: Liu, Xiaoyan, et al.
Publicado: (2023)

Origin and evolution of candidate mental retardation genes on the human X chromosome (MRX)
por: Delbridge, Margaret L, et al.
Publicado: (2008)

Processing of DNA Double-Strand Breaks by the MRX Complex in a Chromatin Context
por: Casari, Erika, et al.
Publicado: (2019)

A Randomized, Double‐Blind, Parallel‐Group, Phase 1 Clinical Trial Comparing the Pharmacokinetic, Safety, and Immunogenicity of the Biosimilar HS016 and the Originator Adalimumab in Chinese Healthy Male Subjects
por: Cao, Guoying, et al.
Publicado: (2020)

PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis
por: Quartier, P, et al.
Publicado: (2013)

Pharmacokinetics and Safety of Doripenem in Healthy Chinese Subjects and Monte Carlo Dosing Simulations
por: Wang, Yu, et al.
Publicado: (2022)

First-In-Human Study on Pharmacokinetics, Safety, and Tolerability of Single and Multiple Escalating Doses of Hepenofovir, a Novel Hepatic Targeting Prodrug of Tenofovir in Healthy Chinese Subjects
por: Zhang, Hong, et al.
Publicado: (2022)

Phospho-dependent recruitment of NuA4 by MRX at DNA breaks regulates RPA dynamics during resection
por: Jobin-Robitaille, Olivier, et al.
Publicado: (2013)

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
por: Hong, David S., et al.
Publicado: (2020)

The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant
por: Lauté-Caly, Delphine L., et al.
Publicado: (2019)

Ku complex suppresses recombination in the absence of MRX activity during budding yeast meiosis
por: Yun, Hyeseon, et al.
Publicado: (2019)

The MRX Complex Plays Multiple Functions in Resection of Yku- and Rif2-Protected DNA Ends
por: Bonetti, Diego, et al.
Publicado: (2010)

In Vitro Activity of MRX-8 and Comparators Against Clinical Isolated Gram-Negative Bacilli in China
por: Wu, Shi, et al.
Publicado: (2022)

In vitro activities of contezolid (MRX-I) against drug-sensitive and drug-resistant Mycobacterium tuberculosis
por: An, Huiru, et al.
Publicado: (2023)

A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects
por: Zhang, Hong, et al.
Publicado: (2021)

Novel Missense Mutation A789V in IQSEC2 Underlies X-Linked Intellectual Disability in the MRX78 Family
por: Kalscheuer, Vera M., et al.
Publicado: (2016)

A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity In Vitro and In Vivo
por: Wu, Wenye, et al.
Publicado: (2022)

Pharmacokinetics (PK) of Eravacycline in Subjects with Renal or Hepatic Impairment Compared with Healthy Subjects
por: Horn, Patrick, et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose Regimen
por: Fan, Yaxin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uuv4mj31j622ae3lqjkm8gna5j